Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
0Customers
1Debt Items
3Related Chains
Source-Backed Evidence Depth
Valion Bio, Inc. (VBIO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
2Total relationships
0Distinct source URLs
1High confidence
0.810Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from TIVC graph: alion to support the manufacturing of Entolimod, the Company's lead product candidate. The Company manages its business activities as two operating segments, …
Valion Bio, Inc. Customers
No clients on recordNo downstream customers found in our database for Valion Bio, Inc..
Valion Bio, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
VBIO-DEBT
Debt stack $6.5M
90%
Market cache reports total debt of $6.5M.
Valion Bio, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Valion Bio, Inc..
Valion Bio, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Valion Bio, Inc..
